Sidoti cut shares of ICU Medical, Inc. (NASDAQ:ICUI) from a buy rating to a neutral rating in a report published on Tuesday morning, Marketbeat reports.
Several other equities analysts have also recently issued reports on the company. BidaskClub upgraded ICU Medical from a hold rating to a buy rating in a research note on Saturday. Roth Capital cut ICU Medical from a buy rating to a neutral rating in a research note on Thursday, May 11th. They noted that the move was a valuation call. Finally, Zacks Investment Research upgraded ICU Medical from a strong sell rating to a hold rating in a research note on Tuesday, May 9th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. ICU Medical currently has a consensus rating of Hold and an average price target of $142.50.
ICU Medical (NASDAQ:ICUI) traded down 0.21% during mid-day trading on Tuesday, hitting $169.15. 54,150 shares of the company’s stock traded hands. The firm’s 50-day moving average price is $163.34 and its 200-day moving average price is $151.41. The stock has a market cap of $3.35 billion, a PE ratio of 30.07 and a beta of 0.38. ICU Medical has a one year low of $103.65 and a one year high of $175.73.
ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Wednesday, May 10th. The medical instruments supplier reported $1.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $1.23. The business had revenue of $247.74 million during the quarter, compared to analysts’ expectations of $237.12 million. ICU Medical had a return on equity of 9.63% and a net margin of 18.76%. The business’s quarterly revenue was up 175.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.26 EPS. On average, analysts forecast that ICU Medical will post $4.14 EPS for the current fiscal year.
WARNING: This article was first reported by Mideast Time and is the property of of Mideast Time. If you are viewing this article on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.mideasttime.com/icu-medical-inc-icui-downgraded-by-sidoti-to-neutral/1799537.html.
In related news, Director Robert S. Swinney sold 594 shares of the business’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $160.92, for a total transaction of $95,586.48. Following the completion of the sale, the director now owns 14,793 shares in the company, valued at $2,380,489.56. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Alison D. Burcar sold 18,290 shares of the business’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $160.72, for a total value of $2,939,568.80. Following the sale, the vice president now owns 3,727 shares of the company’s stock, valued at approximately $599,003.44. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 23,384 shares of company stock valued at $3,766,450. 15.90% of the stock is owned by company insiders.
A number of large investors have recently bought and sold shares of ICUI. Castleark Management LLC acquired a new stake in ICU Medical during the fourth quarter valued at $8,112,000. Cypress Wealth Advisors LLC acquired a new stake in ICU Medical during the fourth quarter valued at $238,000. Janus Capital Management LLC boosted its stake in ICU Medical by 276.1% in the fourth quarter. Janus Capital Management LLC now owns 516,469 shares of the medical instruments supplier’s stock valued at $76,108,000 after buying an additional 379,132 shares during the last quarter. First Republic Investment Management Inc. boosted its stake in ICU Medical by 1.8% in the fourth quarter. First Republic Investment Management Inc. now owns 5,150 shares of the medical instruments supplier’s stock valued at $759,000 after buying an additional 92 shares during the last quarter. Finally, Public Sector Pension Investment Board boosted its stake in ICU Medical by 2.9% in the fourth quarter. Public Sector Pension Investment Board now owns 10,472 shares of the medical instruments supplier’s stock valued at $1,543,000 after buying an additional 300 shares during the last quarter. Hedge funds and other institutional investors own 77.95% of the company’s stock.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.